|
|||||
|
|
Safety,pharmacokinetics and pharmacodynamics of multiple‐ascending doses of the novel glucokinase activator AZD1656 in patients with type 2 diabetes mellitus |
|
| Authors: | L A Morrow M Leonsson‐Zachrisson H Ericsson M Wollbratt M Knutsson M Hompesch E Norjavaara |
| Institution: | 1. Profil Institute for Clinical Research, , Chula Vista, CA, USA;2. AstraZeneca R&D, , M?Indal, Sweden |
| Abstract: | |
| Keywords: | glucokinase glucokinase activator type 2 diabetes mellitus |